The mechanisms by which rhinovirus (RV) infections produce lower airway sym
ptoms in asthmatic individuals are not fully established. To determine effe
cts of RV infection on lung epithelial cells, primary human bronchial epith
elial (BE) cells were infected with either RV 16 or RV49, and viral replica
tion, cell viability, and cell activation were measured. Both viral serotyp
es replicated in BE cells at 33 degrees C (Delta TCID50/ml = 2 to 2.5 log u
nits) and at 37 degrees C (Delta TCID50/ml = 1.6 log units), but only high
doses of RV49 (10(6) TCID50/ml) caused cytopathic effects and reduced cell
viability. In addition, regulated on activation, normal T cells expressed a
nd secreted (RANTES) secretion was increased in epithelial cells infected w
ith RV16 or RV49 (243 and 398 pg/ml versus 13 pg/ml uninfected control cell
s), and a similar pattern was seen for RANTES messenger RNA. RV infection a
lso caused increased secretion of interleukin-8 and granulocyte macrophage
colony-stimulating factor, but did not alter expression of either intercell
ular adhesion molecule-1 or human leukocyte-associated antigen-DR. These ob
servations suggest that RVs can replicate in lower airway cells in vivo, an
d support epidemiologic studies that link RV with lower respiratory illness
es. Further, RV-induced secretion of RANTES and other cytokines could trigg
er antiviral immune responses in vivo, but these effects could also contrib
ute to the pathogenesis of respiratory symptoms in subjects with asthma.